NCT06455722 2024-06-12
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
Clinical Trials
284 trialsNCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT05057143 2024-04-01
3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors
Blokhin's Russian Cancer Research Center
Phase NA Unknown
NCT05057195 2024-04-01
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
Blokhin's Russian Cancer Research Center
Phase NA Unknown
NCT03818412 2024-03-22
Circulating Tumor DNA in Soft Tissue Sarcoma
University Health Network, Toronto
Phase NA Unknown
NCT06291662 2024-03-04
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Meyer Children's Hospital IRCCS
Phase NA Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT04842071 2024-02-07
18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase 3 Unknown
NCT05189483 2024-02-07
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
Phase 2 Unknown
NCT05598229 2024-02-07
Application of Douyin in Perioperative Period of Malignant Tumor Patients
Henan Cancer Hospital
Phase NA Unknown
NCT05718778 2024-02-07
Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
Henan Cancer Hospital
Phase NA Unknown
NCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT06217003 2024-01-22
Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College
Phase 2 Unknown
NCT06217224 2024-01-22
PBMT/MTX
Instituto Nacional de Cancer, Brazil
Phase NA Unknown
NCT01541709 2024-01-02
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Phase 2 Unknown
NCT06186986 2024-01-02
CD30 Imaging in Diffuse Large B-cell Lymphoma
University Medical Center Groningen
Phase 3 Unknown
NCT04025931 2023-12-29
Chidamide Combined With Toripalimab in Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05549921 2023-12-27
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
NCT03600649 2023-11-21
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Salarius Pharmaceuticals, LLC
Phase 1 Unknown
NCT06140732 2023-11-20
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Phase 2 Unknown
NCT06125171 2023-11-09
Tucidinostat Plus Apatinib for Advanced Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT04198337 2023-11-07
EFTR
Chinese University of Hong Kong
Phase NA Unknown
NCT06117878 2023-11-07
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT06114173 2023-11-02
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Unknown
NCT03742193 2023-11-01
PROACH
Ruijin Hospital
Phase 2 Unknown
NCT05490667 2023-10-30
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Phase NA Unknown
NCT05684874 2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA Unknown
NCT04074564 2023-10-23
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
HRYZ Biotech Co.
Phase EARLY_PHASE1 Unknown
NCT03420014 2023-10-10
FIBROSARC US
Philogen S.p.A.
Phase 2 Unknown
NCT05329792 2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2 Unknown
NCT05453292 2023-09-28
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
Instituto Ecuatoriano de Enfermedades Digestivas
Phase NA Unknown
NCT05448820 2023-09-21
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Tracon Pharmaceuticals Inc.
Phase 1/2 Unknown
NCT04741438 2023-08-30
RAR-Immune
Centre Leon Berard
Phase 3 Unknown
NCT06008483 2023-08-23
A Dose Finding Study to Treat Bone Tumor(s)
QSAM Therapeutics, Inc.
Phase 1 Unknown
NCT04510714 2023-08-03
BORIS
Instituto do Cancer do Estado de São Paulo
Phase NA Unknown
NCT03890068 2023-08-01
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05266196 2023-08-01
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Salarius Pharmaceuticals, LLC
Phase 1/2 Unknown
NCT05963035 2023-07-27
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Unknown
NCT05707767 2023-07-19
A Prospective Study of Surgical Treatment Strategies for Chordoma
Xuanwu Hospital, Beijing
Phase NA Unknown
NCT05952128 2023-07-19
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT02365441 2023-07-07
ALT GIST
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05487651 2023-05-18
ANCHOR2
Athenex, Inc.
Phase 1 Unknown
NCT05860374 2023-05-16
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT03462316 2023-04-12
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
Sun Yat-sen University
Phase 1 Unknown
NCT04172805 2023-04-12
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04318964 2023-04-12
TAEST16001 in the Treatment of Soft Tissue Sarcoma
Sun Yat-sen University
Phase 1 Unknown